This study was performed on patients admitted to medical and surgical department of Eesfarayen Hospital.
Conditions
Interventions
Intervention 1: Intervention group1: patients admitted to medical and surgical ward
interventions includ: pulsative flushing in time of drug administration, and then check the phlebitis incidence, patency and longevity of peripheral intra venous catheter every 12 hour. Intervention
interventions includ: continuous flushing in time of drug administration, and then check the phlebitis incidence, patency and longevity of peripheral intra venous catheter every 12 hou. Intervention
Sponsors
Esfarayen University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 18 to 65 years old at least 96 hours are hospitalized
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phlebitis incidence. Timepoint: Every 12 hours to 4 days. Method of measurement: Visual Infusion Phelebit Scale.;Catheter patency. Timepoint: Every 12 hours to 4 days. Method of measurement: lack of resistant against injection from peripheral intra venous catheter.;Longevity of peripheral intra venous catheter. Timepoint: Every 12 hours to 4 days. Method of measurement: Maximum catheter longevity in situ is 96 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| Phelebitis of peripheral intra venous catheter. Timepoint: Every 12 hours For 4 days. Method of measurement: Visual Infusion Phelebit Scale.;Catheter patency. Timepoint: Every 12 hours For 4 days. Method of measurement: lack of resistance against of injection.;Catheter longevity. Timepoint: Every 12 hours For 4 days. Method of measurement: catheter remain in situ for maximum for 96 hours. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahbobeh firooz
Faculty of Medical Sciences Esfarayen
Outcome results
None listed